AGT, angiotensinogen, 183

N. diseases: 765; N. variants: 43
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE Compared with DPP4i nonusers, DPP4i users had a lower risk of ESRD (hazard ratio, 0.81; 95% CI, 0.70-0.94; P=.04) and all-cause mortality (hazard ratio, 0.28; 95% CI, 0.23-0.34; P<.001) after adjustments for CKD, advanced CKD, and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use. 30343892 2018
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 Biomarker disease BEFREE Numerous studies have found that angiotensin II (Ang II) participates in podocyte apoptosis and exacerbates progression of end-stage kidney disease (ESKD). 28676854 2017
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE We conclude that heterozygous substitutions at the AGT M235T and REN A/G(I8-83) loci correlate significantly with ESRD in a north Indian population. 25660845 2015
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE Examination of exome sequencing data in African American T2D-ESKD cases and non-diabetic non-nephropathy controls identified two low-frequency variants in the RREB1 gene, a repressor of the angiotensinogen (AGT) gene previously associated with kidney function, as being associated with T2D-ESKD: rs9379084 (P = 0.00087, OR = 0.26; D1171N) and rs41302867 (P = 0.00078, OR = 0.21; splice site variant). 25027322 2014
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE Furthermore, there was no a markedly positive association between AGT M235T gene polymorphism and ESRD susceptibility in overall populations, Asians and Africans. 23065231 2013
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 AlteredExpression disease BEFREE Some patients with uremia due to ESRD exhibited significantly increased mAb 1G12 binding to blood ACE and increased ACE activity towards angiotensin I accompanied by reduced ACE inhibition by inhibitory mAbs and ACE inhibitors. 23166630 2012
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 Biomarker disease BEFREE Discontinuing angiotensin II blockade resulted in recurrent glomerular destabilization, podocyte loss, and progression to ESKD. 21937979 2012
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 Biomarker disease BEFREE However, other endogenous substances with genotoxic properties, which are increased in ESRD, could be involved, such as the blood pressure regulating hormones angiotensin II and aldosterone or the inflammatory cytokine TNF-α. 22069557 2010
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE Among the ACE, AGT, AT1R and CYP gene polymorphisms, only the DD genotype may predispose the individual to increased risk of progression to ESRD in the Chinese population. 21163122 2010
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE This study was designed to evaluate the angiotensin-converting enzyme insertion/deletion (ACE-I/D), angiotensinogen (AGT) M235T, and angiotensin II receptor type 1 (ATR1) A1166C and type 2 (ATR2) C3123A gene polymorphisms as risk factors for progression to ESRD in patients with VUR.Methods. 19288324 2009
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE The aim of this study was to investigate the distribution of angiotensin converting enzyme (ACE), angiotensinogen (AGT) and angiotensin receptor type 1 (ATR1) genetic polymorphisms in children affected by chronic renal failure due to renal hypodysplasia associated with posterior urethral valves or without urethral abnormalities. 16006956 2005
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE In this study, the angiotensinogen -235T allele was found to be related with steroid resistance, renal dysfunction and progression of ESRD in nephrotic syndrome. 16525944 2005
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 AlteredExpression disease BEFREE Twelve-lead electrocardiograms (ECGs), serum electrolytes (sodium, potassium, and calcium), and ACE and angiotensin II levels were obtained 10 to 12 hours after a hemodialysis session in 43 patients with ESRD on chronic hemodialysis [mean age (+/-SD), 55 +/- 14 years]. 16105049 2005
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE We studied the angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms for association with susceptibility to primary vesicoureteral reflux (VUR) and disease progression in 74 Taiwanese children, including 16 with end-stage renal disease (ESRD), and 117 normal controls. 15045574 2004
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. 12728975 2003
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE We analyzed the effects of the AGT M235T and ATR A1166C polymorphisms on hypertension and age at the end stage renal disease (ESRD). 12950120 2003
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE Two hundred and forty-six end-stage renal disease (ESRD) patients on peritoneal dialysis and 183 control subjects, all of Chinese origin, were genotyped for the ACE insertion/deletion (I/D) and the AGT M235T gene polymorphisms. 12675870 2003
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 Biomarker disease BEFREE The alpha-adducin (ADD) gene, alone or in combination with the angiotensinogen (AGT) and the angiotensin-converting enzyme (ACE), is a candidate for abnormal blood pressure regulation and thus for increased susceptibility or faster progression to ESRD. 11918733 2002
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE We examined the A1166C polymorphism at the angiotensin II type 1 (AT1R) locus in patients with end-stage renal disease (ESRD). 12187084 2002
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE The AGT-TT genotype was associated with a faster progression to ESRD in patients with glomerulonephritis (P < 0.05). 11422735 2001
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group. 10916074 2000
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 AlteredExpression disease BEFREE It is of note that the presently reported patient did not exhibit any AGT catalytic activity and even so, he progressed towards end-stage renal disease only at 19 years old. 10737993 2000
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE Our results suggest that polymorphisms at the AGT and ACE gene loci are important markers for predicting progression to chronic renal failure in Caucasian patients with IgA nephropathy. 9259580 1997
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5
0.100 GeneticVariation disease BEFREE There was no interaction between age of onset of ESRF and either the angiotensinogen M235T allele or angiotensin 1 receptor A1166C polymorphism. 9291178 1997